Bleeding Disorders
Guidelines
ISTH releases draft guideline for TTP diagnosis, treatment
The guideline provides recommendations for adult patients with either immune or hereditary TTP, from acute events through remission, including...
News
FDA gives nod to earlier use of Nplate in adults with ITP
The drug is now indicated for newly diagnosed and persistent adult patients with immune thrombocytopenia and an insufficient response to other...
From the Journals
Global blood supply runs low
Worldwide, more than 60% of countries had an inadequate supply of blood to meet the demand for transfusion.
Feature
Translucent particles found in Hemlibra
Genentech says the benefit-risk profile of the hemophilia A product is unchanged, and it will continue to be distributed.
From the Journals
Monthly and twice monthly emicizumab dosing safe for children with severe hemophilia A
The small study confirms the safety of twice-monthly or monthly emicizumab administration for children with severe hemophilia A without inhibitors...
From the Journals
New consensus recommendations on bleeding in acquired hemophilia
The key areas addressed in the global expert consensus statement include the initial management of bleeding and management of location-specific...
From the Journals
Hemophilia prevalence is nearly three times higher than previously reported
Dr. J. Michael Soucie of the Centers for Disease Control and Prevention said having more accurate prevalence data will help improve access to care...
From the Journals
In older patients with immune-mediated TTP, atypical features may delay diagnosis
Thrombocytopenia with anemia should alert physicians to this possible rare diagnosis in older patients with nonspecific neurological abnormalities...
From the Journals
Eltrombopag elicits positive responses in secondary ITP
The drug appears safe among patients with ITP secondary to lymphoproliferative disorders, but more study is needed to determine the potential risk...
Conference Coverage
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
From the Journals
Extended half-life products cut infusions in Europe
A survey of 33 hemophilia centers showed that the use of extended half-life factor VIII and factor IX products dropped infusions by at least 30%...